Robert Dubois, MD, PhD, chief science officer of the National Pharmaceutical Council (NPC), has advised the Department of Veterans Affairs (VA) to be cautious when using the information provided by the Institute for Clinical and Economic Review (ICER)’s drug assessment reports to inform formulary decisions.